{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:46:15Z","timestamp":1771562775967,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jaad.2017.12.063","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T03:27:38Z","timestamp":1515036458000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients"],"prefix":"10.1016","volume":"79","author":[{"given":"Pamela","family":"Funk-Debleds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Ducroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Guillaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Ursic-Bedoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Decullier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Vallin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Euvrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges-Philippe","family":"Pageaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Boillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Dumortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.jaad.2017.12.063_bib1","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0041-1345(96)00152-2","article-title":"Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre","volume":"29","author":"Webb","year":"1997","journal-title":"Transpl Proc"},{"issue":"5","key":"10.1016\/j.jaad.2017.12.063_bib2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/jlts.2002.32977","article-title":"Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation","volume":"8","author":"Saigal","year":"2002","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.jaad.2017.12.063_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jhep.2005.10.010","article-title":"Skin cancers after liver transplantation: what to do?","volume":"44","author":"Euvrard","year":"2006","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.12.063_bib4","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.transproceed.2012.05.005","article-title":"Subsequent nonmelanoma skin cancer after liver transplantation","volume":"44","author":"Herrero","year":"2012","journal-title":"Transpl Proc"},{"issue":"17","key":"10.1016\/j.jaad.2017.12.063_bib5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jaad.2017.12.063_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jaad.2017.12.063_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/TP.0000000000000051","article-title":"Skin cancers after liver transplantation: retrospective single-center study on 371 recipients","volume":"98","author":"Ducroux","year":"2014","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.jaad.2017.12.063_bib8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/jlts.2001.28744","article-title":"Risk factors for development of de novo neoplasia after liver transplantation","volume":"7","author":"Xiol","year":"2001","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.jaad.2017.12.063_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/lv.2000.6352","article-title":"Skin cancer in liver transplant recipients","volume":"6","author":"Otley","year":"2000","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.jaad.2017.12.063_bib10","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.transproceed.2006.08.065","article-title":"Incidence of de novo nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases","volume":"38","author":"Jim\u00e9nez-Romero","year":"2006","journal-title":"Transpl Proc"},{"issue":"3","key":"10.1016\/j.jaad.2017.12.063_bib11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archdermatol.2009.377","article-title":"Boschieroictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study","volume":"146","author":"Tessari","year":"2010","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2017.12.063_bib12","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/01.TP.0000120181.89206.54","article-title":"Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation","volume":"77","author":"Guba","year":"2004","journal-title":"Transplantation"},{"issue":"2 Pt 1","key":"10.1016\/j.jaad.2017.12.063_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0190-9622(99)70185-4","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens","volume":"40","author":"Jensen","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.12.063_bib14","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1600-6143.2009.02997.x","article-title":"Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial","volume":"10","author":"Salgo","year":"2010","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.jaad.2017.12.063_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e3182247ae2","article-title":"Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial","volume":"92","author":"Alber\u00fa","year":"2011","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.063_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jaad.2017.12.063_bib17","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am J Transpl"},{"issue":"10","key":"10.1016\/j.jaad.2017.12.063_bib18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1200\/JCO.2012.45.6376","article-title":"Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus","volume":"31","author":"Hoogendijk-van den Akker","year":"2013","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.jaad.2017.12.063_bib19","doi-asserted-by":"crossref","first-page":"9398","DOI":"10.1128\/JVI.00974-10","article-title":"The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis","volume":"84","author":"Spangle","year":"2010","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.063_bib20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1399-0012.2010.01370.x","article-title":"Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients","volume":"25","author":"Vallin","year":"2011","journal-title":"Clin Transpl"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221830001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221830001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:45:46Z","timestamp":1759272346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221830001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S019096221830001X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.12.063","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.12.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}